Nuclear Receptor ERRγ Protects Against Cardiac Ischemic Injury by Suppressing GBP5 ‐Mediated Myocardial Inflammation
The FASEB Journal · 31.07.2025 · 39 (14)
DOI: 10.1096/fj.202500763r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 10.07.2025. Verfasst von Junhao Qiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Receptors, Estrogen, Inflammation, Myocardial Ischemia, Myocardial Infarction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the State Key Program of National Natural Science Foundation of China, MOST | National Natural Science Foundation of China (NSFC), Shanghai City Committee of Science and Technology Research Projects.
Abstract (Originalsprache)
Myocardial inflammation plays a critical role in the progression of injury following myocardial infarction (MI), yet the transcriptional mechanisms regulating cardiomyocyte inflammation to mitigate post‐ischemic injury remain poorly understood. This study elucidated the role of Estrogen‐Related Receptor Gamma (ERRγ) in modulating the inflammatory response post‐MI, demonstrating that ERRγ expression was downregulated in ischemic tissue and hypoxic neonatal mouse ventricular myocytes (NMVMs). Cardiomyocyte‐specific overexpression of ERRγ reduced infarct size, improved cardiac function, and suppressed excessive myocardial inflammation and pyroptosis by binding to the GBP5 promoter, thereby inhibiting GBP5 transcription and reducing NLRP3 inflammasome assembly. The protective effects of ERRγ overexpression were reversed by overexpressing GBP5, and the ERRγ agonist DY131 also improved cardiac function after MI. These findings suggest that ERRγ activation reduces myocardial ischemic injury by regulating cardiomyocyte inflammation and pyroptosis, highlighting ERRγ as a potential novel therapeutic target for attenuating post‐MI injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Yi-Gang Li
Förderung
- the State Key Program of National Natural Science Foundation of China
- MOST | National Natural Science Foundation of China (NSFC)
- Shanghai City Committee of Science and Technology Research Projects
- MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities)
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Qiu, J., Che, Q., Zhang, Y., Chen, M., Wei, Z., Bai, Y., Zhao, T., Yan, J., Wu, Z., Fei, Z., Wang, Y., Wang, Q., & Li, Y. G. (2025). Nuclear Receptor ERRγ Protects Against Cardiac Ischemic Injury by Suppressing GBP5 ‐Mediated Myocardial Inflammation. The FASEB Journal, 39(14). https://doi.org/10.1096/fj.202500763r
Vancouver
Qiu J, Che Q, Zhang Y, Chen M, Wei Z, Bai Y, et al. Nuclear Receptor ERRγ Protects Against Cardiac Ischemic Injury by Suppressing GBP5 ‐Mediated Myocardial Inflammation. The FASEB Journal. 2025;39(14). doi:10.1096/fj.202500763r
BibTeX
@article{Qiu2025,
author = {Qiu, Junhao and Che, Qianji and Zhang, Yichao and Chen, Mu and Wei, Zhixing and Bai, Yangjinming and Zhao, Tingting and Yan, Ji and Wu, Zhengyang and Fei, Zhentao and Wang, Yuepeng and Wang, Qian and Li, Yi-Gang},
title = {Nuclear Receptor ERRγ Protects Against Cardiac Ischemic Injury by Suppressing GBP5 ‐Mediated Myocardial Inflammation},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {14},
doi = {10.1096/fj.202500763r}
}
EUVIMED